people who inject drugs

Understanding injecting drug use in Afghanistan: A scoping review

Scientific article

Background Several reports have described a growing prevalence of illicit drug use in Afghanistan, with recognition of a recent shift from traditional modes of consumption involving inhalation and oral ingestion to injecting drug use...

HIV and People Who Use Drugs Factsheet

Leaflet, Infographic, Fact sheet, Poster

The 2021-2026 Global AIDS Strategy has bold and critical new targets on realizing human rights, reducing stigma, discrimination, and violence, and removing harmful punitive laws as a pathway to ending inequalities and ultimately ending AIDS...

Increase access to hepatitis C (HCV) testing and care in drug services- a toolkit

Website

People who inject drugs (PWID) are a key population for the elimination of hepatitis C in Europe, and increasing their access to HCV testing and care is a goal in European and national hepatitis C policies. Despite this, HCV testing remains...

Gender Matters? How Does Gender Shape Risk Environment for Syringe Sharing among People who Inject Drugs in Northern Mexico. Results from a Cross-Sectional Survey

Scientific article

Abstract Introduction. HIV prevalence among people who inject drugs (PWID) is 5%. Studies have found an HIV prevalence of around 10% among women who inject drugs (WWID) and 5% among men. Objective. To describe characteristics of risk...

Key Findings from the Illicit Drug Reporting System (IDRS) Interviews

Book

The Illicit Drug Reporting System (IDRS) is an ongoing illicit drug monitoring system which has been conducted in all states and territories of Australia since 2000 and forms part of Drug Trends. This year, we have provided a suite of...

Monitoring the Elimination of Viral Hepatitis as a Public Health Threat in Europe

Book

This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID). The barometer is being developed by the EMCDDA...

'Connections during Crisis’ – Preventing Drug Deaths in Scotland

29 August 2019

Glasgow

United Kingdom

Join us at our upcoming conference on

Hepatitis C New Models of Care for Drugs Services

Book

28 July 2019

Hepatitis C virus (HCV) infection has a high prevalence in people who inject drugs in Europe, although HCV infection is both preventable and curable. European clinical guidelines recommend that all patients with chronic liver disease as a...

Inactivation of HCV and HIV by Microwave: A Novel Approach for Prevention of Virus Transmission among People who Inject Drugs

Scientific article

18 November 2016

Abstract Hepatitis C virus (HCV) and human immunodeficiency virus (HIV-1) transmissions among people who inject drugs (PWID) continue to pose a challenging global health problem. Here, we aimed to analyse a universally applicable...

Beyond Cure: Patient Reported Outcomes of Hepatitis C Treatment among People who Inject Drugs in Australia

Scientific article

15 August 2018

Abstract Background Recent advances in the treatment of hepatitis C virus (HCV) infection provide the possibility of eliminating HCV as a public health threat. This focus on HCV elimination through treatment, however, is also driving a...